MR microscopy of human amyloid-β deposits: Characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid

Journal of Alzheimer's Disease

Volumn 34, Issue 4, 2013, Pages 1037-1049

  Nabuurs, Rob J A ^a   Natté, Remco ^a   De Ronde, Fenna M ^a   Hegeman Kleinn, Ingrid ^a   Dijkstra, Jouke ^a   Van Duinen, Sjoerd G ^a   Webb, Andrew G ^a   Rozemuller, Annemieke J ^b   Van Buchem, Mark A ^a   Van Der Weerd, Louise ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; amyloid plaque; amyloid ; cerebral amyloid angiopathy; magnetic resonance imaging

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANEURYSM; ARTICLE; ARTIFACT; BRAIN SLICE; BRAIN TISSUE; CADAVER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE PREPARATION; VASCULAR AMYLOIDOSIS;

EID: 84876356036     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122215     Document Type: Article

References (41)

1. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
3. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
4. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
5. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA (1999) Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci U S A 96, 14079-14084.
6. Meadowcroft MD, Connor JR, Smith MB, Yang QX (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging 29, 997-1007.
7. Nabuurs RJ, Hegeman I, Natte R, van Duinen SG, van Buchem MA, van der Weerd L, Webb AG (2011) High-field MRI of single histological slices using an inductively coupled, self-resonant microcoil: Application to ex vivo samples of patients with Alzheimer's disease. NMR Biomed 24, 351-357.
8. van Rooden S, Maat-Schieman ML, Nabuurs RJ, van der Weerd L, van Duijn S, van Duinen SG, Natté R, van Buchem MA, van der Grond J (2009) Cerebral amyloidosis: Postmortem detection with human 7.0-T MR imaging system. Radiology 253, 788-796.
9. Braakman N, Matysik J, van Duinen SG, Verbeek F, Schliebs R, de Groot HJ, Alia A (2006) Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 24, 530-536. (Pubitemid 44320553)
10. Chamberlain R, Reyes D, Curran GL, Marjanska M, Wengenack TM, Poduslo JF, Garwood M, Jack CR Jr (2009) Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease. Magn Reson Med 61, 1158-1164.
11. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA (2004) MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 51, 794-798. (Pubitemid 38420457)
12. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Grohn OH, Grimm R, Poduslo JF (2004) In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 52, 1263-1271. (Pubitemid 39612814)
13. Jack CR Jr,Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 25, 10041-10048. (Pubitemid 41528043)
14. Lee SP, Falangola MF, Nixon RA, Duff K, Helpern JA (2004) Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn Reson Med 52, 538-544. (Pubitemid 39108965)
15. Vanhoutte G, Dewachter I, Borghgraef P, Van LF, Van der Linden A (2005) Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP [V717I] transgenic mice, a model for Alzheimer's disease. Magn Reson Med 53, 607-613. (Pubitemid 40332281)
16. Wengenack TM, Reyes DA, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Gilles EJ, Chamberlain R, Marjanska M, Jack CR Jr, Garwood M, Poduslo JF (2011) Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage 54, 113-122.
17. Ramani A, Jensen JH, Helpern JA (2006) Quantitative MR imaging in Alzheimer disease. Radiology 241, 26-44. (Pubitemid 44433333)
18. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118, 5-36.
19. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
20. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12, 295-312.
21. Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del TK, Braak E, Braak H (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59, 733-748. (Pubitemid 30626743)
22. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800. (Pubitemid 34663580)
23. Thal DR, Griffin WS, Braak H (2008) Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med 12, 1848-1862.
24. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 115, 599-609.
25. Attems J (2005) Sporadic cerebral amyloid angiopathy: Pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110, 345-359. (Pubitemid 41672180)
26. Attems J, Jellinger K, Thal DR, Van NW (2011) Review: Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37, 75-93.
27. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del TK (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112, 389-404. (Pubitemid 44469160)
28. van Duijn S, Nabuurs RJ, van RS, Maat-Schieman ML, van Duinen SG, van Buchem MA, van der Weerd L, Natte R (2011) MRI artifacts in human brain tissue after prolonged formalin storage. Magn Reson Med 65, 1750-1758.
29. Pfefferbaum A, Sullivan EV, Adalsteinsson E, Garrick T, Harper C (2004) Postmortem MR imaging of formalin-fixed human brain. Neuroimage 21, 1585-1595. (Pubitemid 38446582)
30. Shepherd TM, Thelwall PE, Stanisz GJ, Blackband SJ (2009) Aldehyde fixative solutions alter the water relaxation and diffusion properties of nervous tissue. Magn Reson Med 62, 26-34.
31. Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG (2001) Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 50, 765-772. (Pubitemid 33116136)
32. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, Dekosky ST (2008) Post-mortem correlates of in vivo PiBPET amyloid imaging in a typical case of Alzheimer's disease. Brain 131, 1630-1645. (Pubitemid 351806448)
33. Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, Libri V, Leppert D, Beach TG (2007) PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain 130, 2607-2615. (Pubitemid 47511709)
34. Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ (2010) In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology 74, 77-84.
35. Kantarci K, Yang C, Schneider JA, Senjem ML, Reyes DA, Lowe VJ, Barnes LL, Aggarwal NT, Bennett DA, Smith GE, Petersen RC, Jack CR Jr, Boeve BF (2012) Ante mortem amyloid imaging and beta-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging 33, 878-885.
36. Schrag M, Dickson A, Jiffry A, Kirsch D, Vinters HV, Kirsch W(2010) The effect of formalin fixation on the levels of brain transition metals in archived samples. Biometals 23, 1123-1127.
37. Antharam V, Collingwood JF, Bullivant JP, Davidson MR, Chandra S, Mikhaylova A, FinneganME, Batich C, Forder JR, Dobson J (2012) High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: Quantitative imaging and correlation with iron. Neuroimage 59, 1249-1260.
38. Collingwood JF, Chong RK, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Posfai M, Siedlak SL, Simpson ET, Smith MA, Dobson J (2008) Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis 14, 235-245. (Pubitemid 352040039)
39. Miller LM,Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol 155, 30-37. (Pubitemid 43867313)
40. Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, Patino C (2006) Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 153, 42-54. (Pubitemid 43038614)
41. Schrag M, Crofton A, Zabel M, Jiffry A, Kirsch D, Dickson A, Mao XW, Vinters HV, Domaille DW, Chang CJ, KirschW (2011) Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease. J Alzheimers Dis 24, 137-149.